GMO

What GMO does

GMO LLC is a Boston-based, private global investment management firm co-founded in 1977 by Jeremy Grantham. As of December 31, 2025, the firm manages $78.2 billion in assets for institutional investors, family offices, consultants, and intermediaries and wealth managers across the Americas, EMEA, Asia, and Australia/New Zealand. GMO distributes through separately managed accounts (with minimums of $25–$500 million), U.S. mutual funds, ETFs listed on NYSE/ARCA, UCITS, QIFs, Australian Trusts, and private funds, and earns revenue primarily through management and performance fees on AUM.

GMO's product platform spans four asset-class pillars — Multi-Asset Class (e.g., Benchmark-Free Allocation, Global Asset Allocation, Dynamic Allocation ETF), Equities (flagship Quality Strategy launched February 2004 with 150+ bps annual outperformance vs. MSCI World since inception; U.S./International/Quality Spectrum; U.S./International Value; Beyond China; Climate Change; Horizons; Usonian Japan Value; Small Cap Quality), Fixed Income (Emerging Country Debt since 1994, Emerging Country Local Debt since 2008, Multi-Asset Credit, Opportunistic Income, High Yield, Systematic Investment Grade Credit ETF, U.S. Treasury, Ultra-Short Income), and Alternatives (Equity Dislocation since October 2020 with 15.8% gross / 13.4% net in 2025 and 69.3% gross cumulative since inception; Quality Spectrum since October 2019; Systematic Global Macro; World Market Neutral; Event-Driven; Risk Premium).

The investment process is valuation-driven and fundamentally based, combining top-down asset class valuation with bottom-up fundamental and quantitative analysis. It is anchored by two proprietary frameworks: the 7-Year Asset Class Forecast, which projects long-term returns across asset classes to identify attractively priced opportunities, and the multi-decade GMO Quality scoring model (a 0–10 composite on profitability, stability of profitability, and leverage). Distribution is senior-led and consultative on the institutional side, complemented by an event-driven ETF launch cadence (NYSE bell-ringing events) and a content marketing engine built around the GMO Quarterly Letter, white papers, and a research library spanning nearly 50 years. GMO is organized as a partnership/LLC, with co-founder Jeremy Grantham remaining active as Long-Term Investment Strategist and Chairman, alongside named partner-heads of Asset Allocation, Focused Equity, Developed Fixed Income, Emerging Country Debt, and other teams.

Name

GMO

Legal name

GMO LLC

Website

https://www.gmo.com/

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

GMO LLC is a Boston-based private global investment manager (founded 1977) managing $78.2 billion across multi-asset, equity, fixed income, and alternative strategies. It serves institutions, family offices, consultants, and wealth intermediaries via SMAs, mutual funds, ETFs, UCITS, and other global vehicles.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Asset management fees on AUM: GMO generates revenue primarily through management and performance fees on $78.2 billion of assets under management (as of December 31, 2025), offered across separate accounts, U.S. mutual funds, ETFs, UCITS, QIFs, Australian Trusts, and private funds.
2. 13F-reportable public equity portfolio management: GMO's 13F portfolio reached $39.12 billion in Q4 2025 across major U.S. equity holdings including Microsoft, Alphabet, Meta, Apple, and Lam Research, generating fees on actively managed public equity mandates.
3. Alternative / long-short strategy fees: GMO charges fees on alternatives such as Equity Dislocation (returned 15.8% gross / 13.4% net in 2025, 69.3% gross cumulative since October 2020 inception), Quality Spectrum, and Systematic Global Macro strategies.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

GMO LLC is a Boston-based global investment management firm that delivers valuation-driven, fundamentally based active investment strategies across multi-asset, equity, fixed income, and alternative categories. The firm offers these strategies to institutional investors, family offices, consultants, and intermediaries through separately managed accounts (SMAs), U.S. mutual funds, ETFs, UCITS, QIFs, Australian Trusts, and private funds, managing $78.2 billion in assets as of December 31, 2025.

Product overview

GMO LLC is a Boston-based investment management firm (founded 1977, co-founded by Jeremy Grantham) offering a multi-asset platform of valuation-driven strategies, mutual funds, and ETFs rather than a single unified product. The product portfolio spans four asset-class pillars—Multi-Asset Class (e.g., Benchmark-Free Allocation Fund/Strategy, Dynamic Allocation Strategy and its ETF wrapper GMOD, Global Asset Allocation Fund/GAAF), Equities (e.g., flagship Quality Strategy/Quality Fund/QF launched February 2004, Climate Change Strategy/Fund, Horizons Strategy, Beyond China ETF/BCHI, Domestic Resilience ETF/DRES, U.S. Value ETF/GMOV, International Value ETF/GMOI, U.S. Quality ETF/QLTY, International Quality ETF/QLTI, Emerging Markets Fund, Emerging Markets ex-China Fund, Usonian Japan Value/Fund, Small Cap Quality Fund, and others), Fixed Income (e.g., Emerging Country Debt Fund winner of the 2026 LSEG Lipper Award, the new Emerging Country Debt Shares Fund GMAJX, Emerging Country Local Debt Strategy, High Yield Fund, Opportunistic Income Fund, Multi-Asset Credit Strategy/Fund, Systematic Investment Grade Credit ETF/INVG, U.S. Treasury Fund, Ultra-Short Income ETF/GMOC, Multi-Sector Fixed Income Fund), and Alternatives (e.g., Equity Dislocation Strategy/Fund launched October 2020, Quality Spectrum Strategy/Fund launched October 2019, Alternative Allocation Fund, Systematic Global Macro Fund, World Market Neutral Fund, Event-Driven Strategy, Risk Premium Strategy). All products share GMO's valuation-based, transparent, active investment philosophy and are available through separately managed accounts, U.S. mutual funds, ETFs, UCITS, QIFs, Australian Trusts, and private funds; GMO ETFs are distributed by Foreside Fund Services LLC and GMO Trust mutual funds by Funds Distributor LLC. As of December 31, 2025, GMO managed $78.2 billion in assets.

Differentiator

Problem solved

Functional benefit

Brands

• GMO Quality ETF: ETF offering (ticker: QLTY) providing access to GMO's U.S. Quality Strategy.
• GMO U.S. Value ETF
• GMO International Value ETF
• GMO International Quality ETF
• GMO Beyond China ETF
• GMO Systematic Investment Grade Credit ETF
• GMO Ultra-Short Income ETF
• GMO Dynamic Allocation ETF
• GMO Domestic Resilience ETF

Products and services

• Benchmark-Free Allocation Strategy Multi-asset class strategy that allocates without reference to a traditional benchmark, leveraging GMO's 7-Year Asset Class Forecast framework. Available to institutional investors via separately managed accounts, mutual funds, UCITS, and other vehicles.
• Dynamic Allocation Strategy / Dynamic Allocation ETF (GMOD) Actively managed multi-asset ETF that dynamically adjusts exposure to undervalued asset classes globally based on GMO's proprietary forecasts; GMO's first multi-asset ETF, listed on NYSE ARCA under ticker GMOD.
• Global Asset Allocation Strategy / Global Asset Allocation Fund (GAAF) Multi-asset class strategy providing global asset allocation built on GMO's valuation-driven framework; offered via the Global Asset Allocation Fund (GAAF) mutual fund.
• Global Allocation Absolute Return Strategy Multi-asset class strategy focused on absolute return generation through dynamic asset allocation.
• Real Return Global Balanced Asset Allocation Strategy Real-return-oriented global balanced asset allocation strategy.
• Quality Strategy / Quality Fund (QF) GMO's flagship long-only quality equity strategy, launched in 2004, owning attractively valued stocks within the quality universe; offered as the Quality Fund (QF) mutual fund. Has delivered 150+ basis points of annual outperformance versus MSCI World since 2004 with lower volatility.
• U.S. Quality Strategy / U.S. Quality ETF (QLTY) U.S.-domiciled sub-strategy of GMO's flagship Quality Strategy, investing primarily in U.S. quality companies; offered via the U.S. Quality ETF (ticker QLTY) on NYSE.
• International Quality Strategy / International Quality ETF (QLTI) Non-U.S. quality equity strategy and ETF (sub-strategy of GMO's flagship Quality Strategy) targeting internationally domiciled quality companies; offered via the International Quality ETF (ticker QLTI).
• U.S. Opportunistic Value Strategy / U.S. Value ETF (GMOV) U.S. deep-value equity strategy, fund, and ETF targeting undervalued U.S. equities; offered via the U.S. Value ETF (ticker GMOV).
• International Opportunistic Value Strategy / International Value ETF (GMOI) International deep-value equity strategy, fund, and ETF targeting undervalued non-U.S. equities; offered via the International Value ETF (ticker GMOI).
• Beyond China Strategy / Beyond China ETF (BCHI) Equity strategy/ETF providing global supply-chain-shifted exposure that avoids China, addressing deglobalization themes; offered via the Beyond China ETF (ticker BCHI).
• Domestic Resilience Strategy / Domestic Resilience ETF (DRES)
• Climate Change Strategy / Climate Change Fund (GCCLX) Global equity strategy/fund investing in companies positioned to benefit from efforts to curb or mitigate long-term effects of climate change; offered via the GMO Climate Change Fund (ticker GCCLX).
• Horizons Strategy Global equity strategy reflecting the view that the world economy is transitioning to a lower carbon future, and that this process will create opportunities for investors to generate excess returns.
• Emerging Markets Strategy / Emerging Markets Fund Emerging-markets equity strategy and mutual fund offering diversified EM equity exposure.
• Emerging Markets ex-China Strategy / Fund Emerging-markets equity strategy and fund that excludes China-domiciled companies.
• Small Cap Quality Strategy / Small Cap Quality Fund U.S. small-cap quality equity strategy and fund, launched August 2022, applying GMO's quality approach to the small-cap universe.
• U.S. Small Cap Value Strategy / U.S. Small Cap Value Fund U.S. small-cap value equity strategy and mutual fund.
• Usonian Japan Value Strategy Japan-focused equity strategy applying GMO's valuation-driven Usonian approach.
• Usonian Japan Value Creation Strategy / Fund Japan-focused equity strategy/fund targeting Japanese companies undergoing corporate-governance-driven value creation.
• Resources Strategy / Resources Fund (RF) Equity strategy and fund investing in global natural-resource companies; offered via the Resources Fund (RF).
• Resource Transition Strategy / Resource Transition Fund Equity strategy and fund focused on the resource transition theme.
• U.S. Equity Strategy / U.S. Equity Fund U.S. equity strategy and mutual fund providing domestic equity exposure.
• Equity Dislocation Strategy / Equity Dislocation Fund Long/short alternatives strategy launched October 2020 that exploits the valuation gap between cheap value and expensive growth U.S. stocks. Returned 15.8% gross (13.4% net) in 2025 with 69.3% gross cumulative since October 2020 inception.
• Quality Spectrum Strategy / Quality Spectrum Fund Defensive equity/absolute-return long-short strategy launched October 2019, balancing a long book of high-quality businesses (~40-50 names) against a short book of ~300+ low-quality 'junk' names with a 175/75 long/short weighting.
• Alternative Allocation Strategy / Alternative Allocation Fund Multi-strategy alternatives allocation strategy and mutual fund.
• Systematic Global Macro Strategy / Fund Systematic global-macro alternatives strategy and fund.
• World Market Neutral Strategy / Fund Market-neutral alternatives strategy and fund targeting equity-market-neutral returns.
• Emerging Country Debt Strategy / Emerging Country Debt Shares Fund (GMAJX) Hard-currency emerging-markets debt strategy; recognized with the 2026 LSEG Lipper Fund Award in Emerging Markets Hard Currency Debt for its three-year risk-adjusted performance since its 1994 inception. New Emerging Country Debt Shares Fund (ticker GMAJX) launched in March 2026 to provide broader U.S. access.
• Emerging Country Local Debt Strategy GMO's flagship local-currency-benchmarked emerging-markets debt strategy, targeting total return in excess of the J.P. Morgan GBI-EM Global Diversified Index. Inception 2008.
• Multi-Asset Credit Strategy / Multi-Asset Credit Fund Dynamic, benchmark-agnostic multi-asset credit strategy that allocates across Emerging Country Debt, Structured Products, High Yield, Investment Grade, Loans and Mortgages to harvest the most attractively priced credit risk premia based on top-down and bottom-up fundamental and quantitative analysis.
• High Yield Strategy / High Yield Fund Quantitative, factor-based systematic U.S. high-yield credit strategy and mutual fund.
• Systematic Investment Grade Credit Strategy / Systematic Investment Grade Credit ETF (INVG) Bottom-up, factor-based systematic U.S. investment-grade corporate credit strategy and ETF; offered via the Systematic Investment Grade Credit ETF (ticker INVG).
• Ultra-Short Income Strategy / Ultra-Short Income ETF (GMOC) Actively managed ultra-short-duration fixed-income ETF targeting current income while preserving capital through high-quality, short-duration fixed income securities; offered via the Ultra-Short Income ETF (ticker GMOC).
• Opportunistic Income Strategy / Opportunistic Income Fund Unconstrained securitized-credit strategy and fund with low historical market beta and capital-preservation focus.
• U.S. Treasury Strategy / U.S. Treasury Fund U.S. Treasury fixed-income strategy and mutual fund.

Quantifiable outcome

• Equity Dislocation strategy returned 15.8% gross / 13.4% net in 2025; 69.3% gross cumulative since October 2020 inception
• +3 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core operational partner.

• Foreside Fund Services LLCcore operational partnerChannel Partner/ Reseller/ DistributorForeside Fund Services LLC distributes the GMO ETFs in the United States. GMO notes that GMO and Foreside Fund Services LLC are not affiliated, indicating a third-party distribution arrangement for the firm's ETF suite (QLTY, GMOV, GMOD, GMOI, INVG, BCHI, DRES, GMOC, QLTI).
• Funds Distributor LLCcore operational partnerChannel Partner/ Reseller/ DistributorFunds Distributor LLC distributes the GMO Trust mutual funds in the United States across multi-asset, equity, alternative, and fixed-income strategies. GMO and Funds Distributor LLC are not affiliated, indicating a third-party mutual fund distribution arrangement.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Dodge & Cox: San Francisco-based employee-owned active investment manager focused on long-term value and quality equity and fixed income strategies for institutional and individual investors. Closely comparable to GMO in ownership structure (private/partnership), philosophy (valuation-driven, contrarian), and product mix (mutual funds, SMAs, multi-asset).
• Dimensional Fund Advisors: Austin-based private asset manager applying academic factor research (value, profitability, size) to systematic global equity, fixed income, and multi-asset portfolios. Directly comparable to GMO on philosophy (quality and value factor emphasis) and on competing for sophisticated institutional and advisor mandates.
• Capital Group: Private, multi-affiliate investment manager with a deep American Funds mutual fund franchise, multi-asset capabilities, and long-tenured fundamental equity teams. Comparable to GMO as a large private active manager offering institutional separate accounts, mutual funds, and increasingly ETFs.
• T. Rowe Price: Publicly traded global asset manager offering active equity, fixed income, multi-asset, and alternatives strategies across institutional and intermediary channels. Comparable to GMO across product breadth, institutional orientation, and active management heritage, with broader scale and a publicly listed parent.
• PIMCO: Newport Beach-based private global investment manager specializing in active fixed income, multi-asset, alternatives, and ETFs. Comparable to GMO on multi-asset and credit franchise (Multi-Asset Credit Strategy vs. PIMCO Income/Tactical) and on offering UCITS, ETFs, and institutional SMAs.
• Western Asset Management: Pasadena-based active fixed-income manager (Franklin Templeton subsidiary) emphasizing multi-sector, global, and emerging market debt. Comparable to GMO on active EM debt expertise (Emerging Country Debt Fund), multi-asset credit orientation, and institutional client focus.
• Artisan Partners: Publicly listed active asset manager offering high-conviction equity and fixed-income strategies through institutional and intermediary channels. Comparable to GMO on boutique-style, high-conviction fundamental equity franchises (Quality, Value) and selective product proliferation.
• Janus Henderson Investors: London- and Denver-based global active manager offering equities, fixed income, multi-asset, and alternatives to institutional and intermediary clients. Comparable to GMO across multi-asset, equities, and alternatives products and global distribution (UCITS, mutual funds, ETFs, SMAs).
• Loomis Sayles: Boston-based (Natixis subsidiary) active fixed-income and equity manager with deep value, credit, and multi-asset capabilities for institutional and intermediary clients. Comparable to GMO on Boston-based fixed-income franchise, value tilt, and active management heritage.

Broad incumbents

• Federated Hermes: Pittsburgh-based global investment manager offering money market, equity, fixed income, and ESG products across institutional and intermediary channels. Comparable to GMO on multi-affiliate mutual fund and ETF distribution and active fixed income, though broader scale and money market focus differentiate it.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gmo
• Xx.com/GMOInsights

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GMO